Potential health and economic impact associated with achieving risk factor control in Chinese adults with diabetes: a microsimulation modelling study

Double hits with bioactive nanozyme based on cobalt-doped nanoglass for acute and diabetic wound therapies through anti-inflammatory and pro-angiogenic functions

“…The regeneration of pathological wounds, such as those associated with diabetic ulcers, vascular deficits, hypertension, and chronic kidney disease, poses a significant challenge in clinical settings [ 1 , 2 ]. They are commonly accompanied by severe inflammation, including excessive production of reactive oxygen species (ROS) and the presence of pro-inflammatory cytokines [ [3] , [4] , [5] , [6] ].…”

Effectiveness and safety of once‐weekly subcutaneous semaglutide versus other glucose‐lowering agents in real‐world patients with type 2 diabetes: A retrospective, observational post‐marketing study

“…Diabetes facts and figures show the growing global burden for individuals, families and countries nowhere more so than in China 1 . In the ongoing struggle to manage type 2 diabetes (T2DM), achieving glycated haemoglobin (HbA1c) targets remains a formidable task for many patients.…”

“…

Diabetes facts and figures show the growing global burden for individuals, families and countries nowhere more so than in China. 1 In the ongoing struggle to manage type 2 diabetes (T2DM), achieving glycated haemoglobin (HbA1c) targets remains a formidable task for many patients. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have demonstrated their multiple beneficial effects in reducing HbA1c, promoting weight loss and improving cardiovascular survival, as recognized by the most recent national and international guidelines.

…”

Cost‐utility analysis and drug pricing for tirzepatide for type 2 diabetes in the Chinese market compared with semaglutide

“…1 In China, from 1990 to 2016, diabetes-related mortality rates increased by 63.5% and attributable DALYs increased by 95%. 2 Research has shown that increased body mass index (BMI), which is reported in 52.2% of cases, is the primary cause of diabetes-related DALYs. 1 In addition, diabetic complications such as neuropathy, nephropathy, retinopathy and cardiovascular (CV) diseases have significant negative effects on the economy.…”

“…In 2021, it was estimated that type 2 diabetes accounted for 96% of all cases of diabetes worldwide and contributed to 95.4% of diabetes‐related disability‐adjusted life years (DALYs) 1 . In China, from 1990 to 2016, diabetes‐related mortality rates increased by 63.5% and attributable DALYs increased by 95% 2 . Research has shown that increased body mass index (BMI), which is reported in 52.2% of cases, is the primary cause of diabetes‐related DALYs 1 .…”